InvestSMART

Medibank Private Limited (ASX: MPL) - Announcements

Current share price for MPL : $5.130 0.07 (1.38%)+

ASX company news and announcements for Medibank Private Limited (MPL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medibank Private Limited (MPL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medibank Private Limited (MPL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medibank Private Limited (MPL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$14,128 Ceasing to be a substantial holder from NAB 30 Mar 2016 3:34PM $2.860 $5.130 risen by 79.37%
$14,128 Medibank appoints Craig Drummond as MD and CEO 29 Mar 2016 8:28AM $2.840 $5.130 risen by 80.63%
$14,128 Becoming a substantial holder 17 Mar 2016 8:26AM $2.730 $5.130 risen by 87.91%
$14,128 Becoming a substantial holder from NAB 9 Mar 2016 3:37PM $2.785 $5.130 risen by 84.20%
$14,128 Ceasing to be a substantial holder from NAB 4 Mar 2016 4:11PM $2.790 $5.130 risen by 83.87%
$14,128 Revised Share Trading Policy 2 Mar 2016 9:43AM $2.580 $5.130 risen by 98.84%
$14,128 2016 Premium changes approved by Federal Government 2 Mar 2016 8:22AM $2.580 $5.130 risen by 98.84%
$14,128 Becoming a substantial holder from NAB 23 Feb 2016 3:20PM $2.495 $5.130 risen by 105.61%
$14,128 HY 16 Results - Investor Presentation 19 Feb 2016 8:35AM $2.500 $5.130 risen by 105.20%
$14,128 HY 16 Results - Media Release 19 Feb 2016 8:31AM $2.500 $5.130 risen by 105.20%
$14,128 Dividend/Distribution - MPL 19 Feb 2016 8:26AM $2.500 $5.130 risen by 105.20%
$14,128 HY 16 Results - App 4D & Financial Report 19 Feb 2016 8:18AM $2.500 $5.130 risen by 105.20%
$14,128 Resubmission of 2016 Premium Rate Change Application 22 Jan 2016 8:35AM $2.240 $5.130 risen by 129.02%
$14,128 Update to FY16 Health Insurance Financial Targets 22 Jan 2016 8:25AM $2.240 $5.130 risen by 129.02%
$14,128 Change of Director's Interest - Christine O'Reilly 10 Dec 2015 6:00PM $2.150 $5.130 risen by 138.60%
$14,128 Change of Director's Interest - Elizabeth Alexander 10 Dec 2015 5:57PM $2.150 $5.130 risen by 138.60%
$14,128 ISU: AHM Agreement 17 Nov 2015 10:13AM $2.330 $5.130 risen by 120.17%
$14,128 Change of Director's Interest - George Savvides 29 Oct 2015 1:46PM $2.390 $5.130 risen by 114.64%
$14,128 Issue of Securities - Performance Rights 29 Oct 2015 1:41PM $2.390 $5.130 risen by 114.64%
$14,128 Investor Day - Presentation 27 Oct 2015 8:28AM $2.440 $5.130 risen by 110.25%
$14,128 Results of AGM 21 Oct 2015 1:34PM $2.520 $5.130 risen by 103.57%
$14,128 AGM - Chairman and Managing Director Presentations 21 Oct 2015 10:28AM $2.515 $5.130 risen by 103.98%
$14,128 Retirement of Managing Director 21 Oct 2015 9:53AM $2.550 $5.130 risen by 101.18%
$14,128 Appointment of Executive 19 Oct 2015 2:30PM $2.530 $5.130 risen by 102.77%
$14,128 Change of Director's Interest - Peter Hodgett 29 Sep 2015 12:58PM $2.420 $5.130 risen by 111.98%

451 - 475 of 490 results

Page 19 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.